New study aims to sharpen epilepsy surgery decisions

NCT ID NCT06794606

Recruiting now Knowledge-focused Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at people with drug-resistant focal epilepsy, a condition where seizures start in one part of the brain and don't respond to medication. Researchers will use advanced tests to better pinpoint the seizure source and guide treatment, which may include surgery or less invasive options like focused ultrasound or nerve stimulation. The goal is to improve patient selection and outcomes for these treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could improve how doctors select patients for epilepsy surgery or alternative treatments, leading to better seizure control and quality of life.
What could go wrong: This is an observational study that gathers data, not a direct test of a new treatment. It may not lead to immediate changes in care, and results depend on careful patient selection.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DRUG-RESISTANT FOCAL EPILEPSY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

epilepsy focal epilepsy

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

EPILEPSY

Contacts and locations

Locations

Foundation IRCCS Carlo Besta Neurological Institute
RECRUITING

Milan, 20133, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.